Pletcher Brett A's Form 4 filing
Gilead Sciences, Inc. (GILD) · filed Mar 14, 2022
- Accession no.
- 0001127602-22-009215
- Filed
- Mar 14, 2022
- Trade date
- Mar 10-11, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $211.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pletcher Brett ACIK 0001739307 | Officer (EVP,Corp Affairs & Gen Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2022 | Common Stock | MOption exerciseAcquired | +2,593 | –F1 | – | 35,169 | Direct | |
| Mar 10, 2022 | Common Stock | MOption exerciseAcquired | +3,130 | –F1 | – | 38,299 | Direct | |
| Mar 10, 2022 | Common Stock | FTax withholdingDisposed | −2,089 | $57.92 | −$120,994.88 | 36,210 | Direct | |
| Mar 11, 2022 | Common Stock | SSaleDisposed | −3,634 | $58.24 | −$211,644.16 | 32,576 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.